Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feinsilver, S.
Right arrow Articles by Braman, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Feinsilver, S.
Right arrow Articles by Braman, S.

Chest, Vol 90, 516-519, Copyright © 1986 by American College of Chest Physicians

ARTICLES

Fiberoptic bronchoscopy and pleural effusion of unknown origin

SH Feinsilver, AA Barrows and SS Braman

We reviewed our experience with fiberoptic bronchoscopy (FOB) in patients with pleural effusion of unknown origin. Seventy patients underwent FOB for the investigation of pleural effusion between 1978 and 1983. Those with a second reason for FOB, a mass on chest roentgenogram, or lobar atelectasis were excluded. Forty five patients remained: 28 patients with unexplained pleural effusion after pleural fluid analysis and pleural biopsy (UPE), and 17 patients with malignant pleural fluid cytology and/or pleural biopsy but no known primary tumor (MPE). In the UPE group, only one FOB demonstrated malignancy, despite a final diagnosis of tumor in seven. No other specific diagnoses were made by FOB in this group. In the MPE group, FOB demonstrated bronchogenic carcinoma in two; ultimately, five patients were found to have a bronchogenic neoplasm. Although pleural effusion of unknown origin is frequently caused by bronchogenic carcinoma, FOB in the absence of other indications for this procedure is rarely diagnostic and should not be routinely employed.


This article has been cited by other articles:


Home page
 ChestHome page
B. Chakrabarti, I. Ryland, J. Sheard, C. J. Warburton, and J. E. Earis
The Role of Abrams Percutaneous Pleural Biopsy in the Investigation of Exudative Pleural Effusions
Chest, June 1, 2006; 129(6): 1549 - 1555.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
N A Maskell and R J A Butland
BTS guidelines for the investigation of a unilateral pleural effusion in adults
Thorax, May 1, 2003; 58(90002): ii8 - 17.
[Full Text]

Home page
 Eur Respir JHome page
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn
Management of malignant pleural effusions
Eur. Respir. J., August 1, 2001; 18(2): 402 - 419.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
Management of Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American College of Chest Physicians.